Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides

Peptide-based nanoparticles (PBN) for nucleotide complexation and targeting of extrahepatic diseases are gaining recognition as potent pharmaceutical vehicles for fine-tuned control of protein production (up- and/or down-regulation) and for gene delivery. Herein, we review the principles and mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Wickline, Samuel A., Hou, Kirk K., Pan, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253970/
https://www.ncbi.nlm.nih.gov/pubmed/37298407
http://dx.doi.org/10.3390/ijms24119455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253970/
https://www.ncbi.nlm.nih.gov/pubmed/37298407
http://dx.doi.org/10.3390/ijms24119455

Ejemplares similares